These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31948857)

  • 1. Corrigendum to 'Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways'. [Int. Immunopharmacol. 75 (2019) 105739].
    Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G
    Int Immunopharmacol; 2020 Jul; 84():105962. PubMed ID: 31948857
    [No Abstract]   [Full Text] [Related]  

  • 2. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
    Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G
    Int Immunopharmacol; 2019 Oct; 75():105739. PubMed ID: 31351366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to 'Protective effect of kobophenol A on nitric oxide-induced cell apoptosis in human osteoblast-like MG-63 cells: Involvement of JNK, NF-κB and AP-1 pathways' [Int. Immunopharmacol. 11 (2011) 1251-1259].
    Lee SR; Kwak JH; Park DS; Pyo S
    Int Immunopharmacol; 2019 Jan; 66():388. PubMed ID: 30473316
    [No Abstract]   [Full Text] [Related]  

  • 4. Farrerol inhibits IL-6 and IL-8 production in LPS-stimulated human gingival fibroblasts by suppressing PI3K/AKT/NF-κB signaling pathway.
    Wang Q; Zhang B; Yu JL
    Arch Oral Biol; 2016 Feb; 62():28-32. PubMed ID: 26615574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farrerol Relieve Lipopolysaccharide (LPS)-Induced Mastitis by Inhibiting AKT/NF-κB p65, ERK1/2 and P38 Signaling Pathway.
    Li Y; Gong Q; Guo W; Kan X; Xu D; Ma H; Fu S; Liu J
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29904013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peiminine Protects Dopaminergic Neurons from Inflammation-Induced Cell Death by Inhibiting the ERK1/2 and NF-κB Signalling Pathways.
    Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Liu D; Fu S
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson's Disease in Rats.
    He D; Huang B; Fu S; Li Y; Ran X; Liu Y; Chen G; Liu J; Liu D
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum to "Alpha-Mangostin suppresses interleukin-1β-induced apoptosis in rat chondrocytes by inhibiting the NF-κB signaling pathway and delays the progression of osteoarthritis in a rat model" [Int. Immunopharmacol. 52 (2017) 156-162].
    Pan T; Chen R; Wu D; Cai N; Shi X; Li B; Pan J
    Int Immunopharmacol; 2018 Dec; 65():559-560. PubMed ID: 30412853
    [No Abstract]   [Full Text] [Related]  

  • 9. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway.
    Yan X; Liu DF; Zhang XY; Liu D; Xu SY; Chen GX; Huang BX; Ren WZ; Wang W; Fu SP; Liu JX
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to "Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways" [Int. Immunopharmacol. 55 (2018) 9-19].
    Li J; Bao L; Zha D; Zhang L; Gao P; Zhang J; Wu X
    Int Immunopharmacol; 2024 Jan; 126():111252. PubMed ID: 38040552
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Gypsophila elegans isoorientin-2″-O-α-L-arabinopyranosyl ameliorates porcine serum-induced immune liver fibrosis by inhibiting NF-κB signaling pathway and suppressing HSC activation" [Int. Immunopharmacol. 54 (2018) 60-67].
    Bai F; Huang Q; Wei J; Lv S; Chen Y; Liang C; Wei L; Lu Z; Lin X
    Int Immunopharmacol; 2023 Sep; 122():110697. PubMed ID: 37500383
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of concern to "Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K/Akt signaling pathway" [Int. Immunopharmacol. 75 (2019) 105734].
    Cai L; Tu L; Li T; Yang X; Ren Y; Gu R; Zhang Q; Yao H; Qu X; Wang Q; Tian J
    Int Immunopharmacol; 2023 Jan; 114():109459. PubMed ID: 36596085
    [No Abstract]   [Full Text] [Related]  

  • 13. Calycosin attenuates MPTP-induced Parkinson's disease by suppressing the activation of TLR/NF-κB and MAPK pathways.
    Yang J; Jia M; Zhang X; Wang P
    Phytother Res; 2019 Feb; 33(2):309-318. PubMed ID: 30421460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diosgenin Attenuates Lipopolysaccharide-Induced Parkinson's Disease by Inhibiting the TLR/NF-κB Pathway.
    Li B; Xu P; Wu S; Jiang Z; Huang Z; Li Q; Chen D
    J Alzheimers Dis; 2018; 64(3):943-955. PubMed ID: 29966203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to "4-Hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice" [Int. Immunopharmacol. 83 (2020) 106445].
    Wang H; Wei X; Wei X; Sun X; Huang X; Liang Y; Xu W; Zhu X; Lin X; Lin J
    Int Immunopharmacol; 2020 Sep; 86():106722. PubMed ID: 32593975
    [No Abstract]   [Full Text] [Related]  

  • 16. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
    Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to "Melatonin inhibits the formation of chemically induced experimental encapsulating peritoneal sclerosis through modulation of T cell differentiation by suppressing of NF-κB activation in dendritic cells" [Int. Immunopharmacol. 126 (2024) 111300].
    Huang SH; Hong ZJ; Chen MF; Tsai MW; Chen SJ; Cheng CP; Sytwu HK; Lin GJ
    Int Immunopharmacol; 2024 Apr; 131():111683. PubMed ID: 38368242
    [No Abstract]   [Full Text] [Related]  

  • 18. Retraction notice to "Corrigendum to "MLL1 promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis by activating the TRIF/NF-κB signaling pathway via H3K4me3 enrichment in the TLR4 promoter region"" [Int. Immunopharmacol. 82 (2020) 106220] [Int. Immunopharmacol. 92 (2021) 107321].
    Zhang Y; Ji T; Ma S; Wu W
    Int Immunopharmacol; 2023 Apr; 117():109865. PubMed ID: 36822094
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation of Sonic hedgehog signal by Purmorphamine, in a mouse model of Parkinson's disease, protects dopaminergic neurons and attenuates inflammatory response by mediating PI3K/AKt signaling pathway.
    Shao S; Wang GL; Raymond C; Deng XH; Zhu XL; Wang D; Hong LP
    Mol Med Rep; 2017 Aug; 16(2):1269-1277. PubMed ID: 28627590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farrerol Ameliorates TNBS-Induced Colonic Inflammation by Inhibiting ERK1/2, JNK1/2, and NF-κB Signaling Pathway.
    Ran X; Li Y; Chen G; Fu S; He D; Huang B; Wei L; Lin Y; Guo Y; Hu G
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.